EFFECTS OF RAMIPRIL, TELMISARTAN AND THEIR COMBINATION ON AMBULATORY BLOOD PRESSURE IN AN ONTARGET SUBSTUDY

被引：0
|
作者：
Mancia, G. [1 ]
Parati, G. [1 ]
Bilo, G. [1 ]
Giglio, A. [1 ]
Gao, P. [2 ]
Verdecchia, P. [3 ]
Redon, J. [4 ]
Sleight, P. [5 ]
Fagard, R. H. [6 ]
Yusuf, S. [2 ]
Teo, K. [2 ]
机构：
[1] Univ Milano Bicocca, Ist Auxol Italiano, Milan, Italy
[2] McMaster Univ, Hamilton, ON, Canada
[3] Hosp S Maria della Misericordia, Perugia, Italy
[4] Univ Valencia, Valencia, Spain
[5] John Radcliffe Hosp, Oxford OX3 9DU, England
[6] Univ Louvain, Leuven, Belgium
来源：
JOURNAL OF HYPERTENSION | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)
    Mancia, Giuseppe
    Parati, Gianfranco
    Bilo, Grzegorz
    Gao, Peggy
    Fagard, Robert
    Redon, Josep
    Czuriga, Istvan
    Polak, Martin
    Ribeiro, Jose M.
    Sanchez, Ramiro
    Trimarco, Bruno
    Verdecchia, Paolo
    van Mieghem, Walter
    Teo, Koon
    Sleight, Peter
    Yusuf, Salim
    HYPERTENSION, 2012, 60 (06) : 1400 - 1406
  • [2] The rationale for choosing telmisartan and ramipril in the ONTARGET programme
    Unger, Thomas
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0F) : F3 - F8
  • [3] Comparative effects of Ramipril on ambulatory and office blood pressures -: A HOPE substudy
    Svensson, P
    de Faire, U
    Sleight, P
    Yusuf, S
    Östergren, J
    HYPERTENSION, 2001, 38 (06) : 1480 - 1480
  • [4] Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
    Mancia, Giuseppe
    Schumacher, Helmut
    Redon, Josep
    Verdecchia, Paolo
    Schmieder, Roland
    Jennings, Garry
    Yusoff, Khalid
    Ryden, Lars
    Liu, G. Lisheng
    Teo, Koon
    Sleight, Peter
    Yusuf, Salim
    CIRCULATION, 2011, 124 (16) : 1727 - U94
  • [5] Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
    Horn, S.
    JOURNAL FUR HYPERTONIE, 2013, 17 (02): : 74 - 75
  • [6] Comparison of the effects of ramipril on ambulatory and office blood pressures. A HOPE substudy
    Svensson, P
    de Faire, U
    Sleight, P
    Yusuf, S
    Ostergren, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 286A - 287A
  • [7] EFFECTS ON AMBULATORY BLOOD PRESSURE OF CHRONOTHERAPY WITH TELMISARTAN-HYDROCHLOROTHIAZIDE COMBINATION IN ESSENTIAL HYPERTENSION
    Hermida, R. C.
    Ayala, D. E.
    Chayan, L.
    Mojon, A.
    Fernandez, J. R.
    JOURNAL OF HYPERTENSION, 2009, 27 : S129 - S130
  • [8] Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])
    Cowan, Brett R.
    Young, Alistair A.
    Anderson, Craig
    Doughty, Robert N.
    Krittayaphong, Rungroj
    Lonn, Eva
    Marwick, Thomas H.
    Reid, Chris M.
    Sanderson, John E.
    Schmieder, Roland E.
    Teo, Koon
    Wadham, Angela K.
    Worthley, Stephen G.
    Yu, Cheuk-Man
    Yusuf, Salim
    Jennings, Garry L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (11): : 1484 - 1489
  • [9] Comparative effects of amlodipine, ramipril and telmisartan on 24-hour ambulatory blood pressure in mild to moderate hypertensive patients
    Poirie, L
    de Champlain, J
    Larochelle, P
    Lamarre-Cliche, M
    Lacourcière, Y
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 196A - 196A
  • [10] Comparative effects of amlodipine, ramipril and telmisartan on 24-hour ambulatory blood pressure in mild to moderate hypertensive patients
    Poirier, L
    de Champlain, J
    Larochelle, P
    Lamarre-Cliche, M
    Lacourcière, Y
    JOURNAL OF HYPERTENSION, 2003, 21 : S11 - S12
12345